COVID-19: Mayo Clinic is committed to taking care of our patients, learners and staff. Learn more about guidelines for the resumption of live
(in-person) courses and conferences
effective July 1, 2021 and available COVID-19 online education and resources.
La Jolla Pharmaceutical Company - Exhibitor


Contact Information:

Chris Cox
Critical Care Specialist
Cell:  612-239-8601

Zoom Information with available hours:

*Virtual Connection Hours:
Wednesday, Nov. 4th
7:00am-7:45 CST
10:15-10:30 CST
2:15-3:00 CST

Thursday, Nov. 5th
7:00am-7:45 CST
10:15-10:30 CST
1:30-2:00 CST

Friday, Nov. 6th
7:00am-7:45 CST
10:15-10:30 CST
1:30-2:00 CST

**Email or text Chris Cox above to arrange alternate meeting times if these hours are not convenient.

Virtual Exhibit Hall Home

About Giapreza Video

La Jolla Pharmaceutical Company is dedicated to the development and commercialization of innovative therapies that improve outcomes in patients suffering from life-threatening diseases.

GIAPREZA™ (angiotensin II) is approved by the U.S. Food and Drug Administration (FDA) as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock.


Giapreza Overview

Giapreza Limited Warranty